Change Agents (CHGA) Q2 2026 earnings summary

Executive summary

• Focused on Agentic AI software and consumer health products, with expansion into drone interception and surveillance AI solutions.

• Operates two segments: AI-driven video generation/SEO tools and Keto Air breathalyzer distribution in North America.

• Ceased laboratory services in Q1 2025 and sold real estate subsidiary in February 2026.

• Name changed to Change Agents Corporation in July 2026; new ticker symbol CHGA on Nasdaq.

Financial highlights

• Net loss for Q2 2026 was $2.18M, down 83.8% year-over-year; six-month net loss was $6.66M, down 58.2%.

• Loss from operations for Q2 2026 was $2.05M, a 47.5% decrease year-over-year.

• Working capital deficit decreased to $4.09M from $12.65M at year-end 2025.

• Cash balance at June 30, 2026 was $39K, down from $109K at year-end 2025.

• Net cash used in operating activities for six months ended June 30, 2026 was $3.56M.

Outlook and guidance

• Substantial doubt exists about ability to continue as a going concern due to recurring losses and limited cash.

• Plans to raise additional capital through equity sales and expand product commercialization.

• Expects increased cash use for product development and marketing in the next 12 months.